1.
Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on Global Remdesivir Market
4. Executive Summary
5.
Voice of Customer
5.1.
Brand Awareness (Aided/Unaided)
5.2.
Product Awareness
5.3.
Customer Satisfaction Analysis
5.4.
Unmet Needs/Challenges
6. Global Remdesivir
Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Dosage Form (Lyophilized Solution, Frozen Solution)
6.2.2. By Route of Administration (Intravenous, Inhalation)
6.2.3. By Patient Age (Geriatric, Adult, Pediatric)
6.2.4. By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola,
SARS-CoV)
6.2.5. By Distribution Channel (Hospitals, Clinics, Drug Stores
and Pharmacies)
6.2.6. By Company (2020)
6.2.7. By Region
6.3.
Product Market Map
7. North America Remdesivir
Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Dosage Form
7.2.2. By Route of
Administration
7.2.3. By Patient Age
7.2.4. By Application
7.2.5. By Distribution
Channel
7.2.6. By Country
7.3.
North America: Country Analysis
7.3.1. United States
Remdesivir Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Dosage Form
7.3.1.2.2.
By Route of Administration
7.3.1.2.3.
By Patient Age
7.3.1.2.4.
By Application
7.3.1.2.5.
By Distribution Channel
7.3.2. Mexico Remdesivir
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Dosage Form
7.3.2.2.2.
By Route of Administration
7.3.2.2.3.
By Patient Age
7.3.2.2.4.
By Application
7.3.2.2.5.
By Distribution Channel
7.3.3. Canada Remdesivir
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Dosage Form
7.3.3.2.2.
By Route of Administration
7.3.3.2.3.
By Patient Age
7.3.3.2.4.
By Application
7.3.3.2.5.
By Distribution Channel
8. Asia-Pacific Remdesivir
Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Dosage Form
8.2.2. By Route of
Administration
8.2.3. By Patient Age
8.2.4. By Application
8.2.5. By Distribution
Channel
8.2.6. By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1. India Remdesivir
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Dosage Form
8.3.1.2.2.
By Route of Administration
8.3.1.2.3.
By Patient Age
8.3.1.2.4.
By Application
8.3.1.2.5.
By Distribution Channel
8.3.2. Japan Remdesivir
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Dosage Form
8.3.2.2.2.
By Route of Administration
8.3.2.2.3.
By Patient Age
8.3.2.2.4.
By Application
8.3.2.2.5.
By Distribution Channel
8.3.3. China Remdesivir
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Dosage Form
8.3.3.2.2.
By Route of Administration
8.3.3.2.3.
By Patient Age
8.3.3.2.4.
By Application
8.3.3.2.5.
By Distribution Channel
8.3.4. South Korea
Remdesivir Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Dosage Form
8.3.4.2.2.
By Route of Administration
8.3.4.2.3.
By Patient Age
8.3.4.2.4.
By Application
8.3.4.2.5.
By Distribution Channel
8.3.5. Australia Remdesivir
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Dosage Form
8.3.5.2.2.
By Route of Administration
8.3.5.2.3.
By Patient Age
8.3.5.2.4.
By Application
8.3.5.2.5.
By Distribution Channel
9. Europe Remdesivir
Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Dosage Form
9.2.2. By Route of
Administration
9.2.3. By Patient Age
9.2.4. By Application
9.2.5. By Distribution
Channel
9.2.6. By Country
9.3.
Europe: Country Analysis
9.3.1. France Remdesivir
Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Dosage Form
9.3.1.2.2.
By Route of Administration
9.3.1.2.3.
By Patient Age
9.3.1.2.4.
By Application
9.3.1.2.5.
By Distribution Channel
9.3.2. United Kingdom
Remdesivir Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Dosage Form
9.3.2.2.2.
By Route of Administration
9.3.2.2.3.
By Patient Age
9.3.2.2.4.
By Application
9.3.2.2.5.
By Distribution Channel
9.3.3. Italy Remdesivir
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Dosage Form
9.3.3.2.2.
By Route of Administration
9.3.3.2.3.
By Patient Age
9.3.3.2.4.
By Application
9.3.3.2.5.
By Distribution Channel
9.3.4. Germany Remdesivir
Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Dosage Form
9.3.4.2.2.
By Route of Administration
9.3.4.2.3.
By Patient Age
9.3.4.2.4.
By Application
9.3.4.2.5.
By Distribution Channel
9.3.5. Spain Remdesivir
Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Dosage Form
9.3.5.2.2.
By Route of Administration
9.3.5.2.3.
By Patient Age
9.3.5.2.4.
By Application
9.3.5.2.5.
By Distribution Channel
10. South America Remdesivir
Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Dosage Form
10.2.2. By Route of
Administration
10.2.3. By Patient Age
10.2.4. By Application
10.2.5. By Distribution
Channel
10.2.6. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Remdesivir
Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Dosage Form
10.3.1.2.2.
By Route of Administration
10.3.1.2.3.
By Patient Age
10.3.1.2.4.
By Application
10.3.1.2.5.
By Distribution Channel
10.3.2. Argentina Remdesivir
Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Dosage Form
10.3.2.2.2.
By Route of Administration
10.3.2.2.3.
By Patient Age
10.3.2.2.4.
By Application
10.3.2.2.5.
By Distribution Channel
10.3.3. Colombia Remdesivir
Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Dosage Form
10.3.3.2.2.
By Route of Administration
10.3.3.2.3.
By Patient Age
10.3.3.2.4.
By Application
10.3.3.2.5.
By Distribution Channel
11. Middle East and
Africa Remdesivir Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Dosage Form
11.2.2. By Route of
Administration
11.2.3. By Patient Age
11.2.4. By Application
11.2.5. By Distribution
Channel
11.2.6. By Country
11.3.
MEA: Country Analysis
11.3.1. Iran Remdesivir
Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Dosage Form
11.3.1.2.2.
By Route of Administration
11.3.1.2.3.
By Patient Age
11.3.1.2.4.
By Application
11.3.1.2.5.
By Distribution Channel
11.3.2. South Africa
Remdesivir Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Dosage Form
11.3.2.2.2.
By Route of Administration
11.3.2.2.3.
By Patient Age
11.3.2.2.4.
By Application
11.3.2.2.5.
By Distribution Channel
11.3.3. UAE Remdesivir
Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Dosage Form
11.3.3.2.2.
By Route of Administration
11.3.3.2.3.
By Patient Age
11.3.3.2.4.
By Application
11.3.3.2.5.
By Distribution Channel
11.3.4. Saudi Arabia
Remdesivir Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1.
By Dosage Form
11.3.4.2.2.
By Route of Administration
11.3.4.2.3.
By Patient Age
11.3.4.2.4.
By Application
11.3.4.2.5.
By Distribution Channel
11.3.5. Kuwait Remdesivir
Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1.
By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1.
By Dosage Form
11.3.5.2.2.
By Route of Administration
11.3.5.2.3.
By Patient Age
11.3.5.2.4.
By Application
11.3.5.2.5.
By Distribution Channel
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Pricing Analysis
15.
Patent Analysis
16.
Competitive Landscape
16.1.
Gilead Sciences, Inc.
16.2.
Cipla Ltd.
16.3.
Hetero Labs Ltd.
16.4.
Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.)
16.5.
Dr Reddy's Laboratories Ltd.
16.6.
Sun Pharmaceutical Industries Ltd.
16.7.
Cadila Healthcare Ltd.
16.8.
Jubilant Pharmova Ltd.
16.9.
Eva Pharma Ltd.
16.10.
Ferozsons Laboratories
17. Strategic Recommendations
18. About Us & Disclaimer
Figure 1: Global
Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 2: Global
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 3: Global
Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 4: Global
Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 5: Global
Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 6: Global
Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 7: Global
Remdesivir Market Share, By Company, By Value, 2020
Figure 8: Global
Remdesivir Market Share, By Region, By Value, 2020-2026F
Figure 9: Global
Remdesivir Product Market Map, By Value, 2020-2026F
Figure 10: North
America Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 11: North
America Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 12: North
America Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 13: North
America Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 14: North
America Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 15: North
America Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 16: North
America Remdesivir Market Share, By Country, By Value, 2020-2026F
Figure 17: United
States Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 18: United
States Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 19: United
States Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 20: United
States Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 21: United
States Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 22: United
States Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 23: Mexico
Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 24: Mexico
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 25: Mexico
Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 26: Mexico
Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 27: Mexico
Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 28: Mexico
Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 29: Canada
Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 30: Canada
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 31: Canada
Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 32: Canada
Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 33: Canada
Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 34: Canada
Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 35: Asia-Pacific
Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 36: Asia-Pacific
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 37: Asia-Pacific
Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 38: Asia-Pacific
Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 39: Asia-Pacific
Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 40: Asia-Pacific
Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 41: Asia-Pacific
Remdesivir Market Share, By Country, By Value, 2020-2026F
Figure 42: India
Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 43: India
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 44: India
Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 45: India
Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 46: India
Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 47: India
Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 48: Japan
Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 49: Japan
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 50: Japan
Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 51: Japan
Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 52: Japan
Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 53: Japan
Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 54: China
Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 55: China
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 56: China
Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 57: China
Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 58: China
Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 59: China
Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 60: South
Korea Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 61: South Korea
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 62: South
Korea Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 63: South
Korea Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 64: South
Korea Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 65: South
Korea Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 66: Australia
Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 67: Australia
Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 68: Australia
Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 69: Australia
Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 70: Australia
Remde